Stay updated with breaking news from Ivan cheung. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
It's been a crazy year, and the Brian Walshe and Karen Read murder trials aren't the only cases with shocking headlines. Here is a rundown of cases this year that Herald readers, and in some cases the nation, have followed from the edge of their seats.
Promising new Alzheimer's drugs may benefit Whites more than Blacks – The Frontier Post thefrontierpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thefrontierpost.com Daily Mail and Mail on Sunday newspapers.
Promising new Alzheimer's drugs may benefit whites more than Blacks By Reuters investing.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investing.com Daily Mail and Mail on Sunday newspapers.
By Julie Steenhuysen NEW YORK (Reuters) - Groundbreaking treatments for Alzheimer's disease that work by removing a toxic protein called beta amyloid ...
Groundbreaking treatments for Alzheimer's disease that work by removing a toxic protein called beta amyloid from the brain may benefit whites more than Black Americans, whose disease may be driven by other factors, leading Alzheimer's experts told Reuters. The two drugs – Leqembi, from partner biotech firms Eisai and Biogen, and an experimental treatment developed by Eli Lilly, donanemab - are the first to offer real hope of slowing the fatal disease for the 6.5 million Americans living with Alzheimer's. Although older Black Americans have twice the rate of dementia as whites, they were screened out of clinical trials of these drugs at a higher rate, according to interviews with 10 researchers as well as 4 Eisai and Lilly executives.
Insight: Promising new Alzheimer's drugs may benefit whites more than Blacks reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.
Alzheimer's drugs Leqembi donanemab may benefit Black people less nbcnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nbcnews.com Daily Mail and Mail on Sunday newspapers.